These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25253173)

  • 1. Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.
    Jung SY; Shin KH; Kim M; Chung SH; Lee S; Kang HS; Lee ES; Kwon Y; Lee KS; Park IH; Ro J
    Breast Cancer Res Treat; 2014 Nov; 148(1):91-8. PubMed ID: 25253173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.
    Kim M; Kim SW; Lee SU; Lee NK; Jung SY; Kim TH; Lee ES; Kang HS; Shin KH
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):498-503. PubMed ID: 23541809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
    Helyer LK; Varnic M; Le LW; Leong W; McCready D
    Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence and risk factors for occurrence of arm lymphedema after treatment of breast cancer.
    Rebegea L; Firescu D; Dumitru M; Anghel R
    Chirurgia (Bucur); 2015; 110(1):33-7. PubMed ID: 25800313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
    Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
    JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
    Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
    Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?
    Hayes SB; Freedman GM; Li T; Anderson PR; Ross E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1449-55. PubMed ID: 19028274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of axillary nodal ratio in stage II/III breast cancer treated with neoadjuvant chemotherapy.
    Keam B; Im SA; Kim HJ; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Cho N; Moon WK; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    Breast Cancer Res Treat; 2009 Jul; 116(1):153-60. PubMed ID: 18787948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
    Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
    Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Prognostic Risk Factors for Transient and Persistent Lymphedema after Multimodal Treatment for Breast Cancer.
    Kim M; Shin KH; Jung SY; Lee S; Kang HS; Lee ES; Chung SH; Kim YJ; Kim TH; Cho KH
    Cancer Res Treat; 2016 Oct; 48(4):1330-1337. PubMed ID: 26875199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer related lymphedema in patients with different loco-regional treatments.
    Ozcinar B; Guler SA; Kocaman N; Ozkan M; Gulluoglu BM; Ozmen V
    Breast; 2012 Jun; 21(3):361-5. PubMed ID: 22460058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors Affecting Breast Cancer-related Lymphedema: Serial Body Weight Change During Neoadjuvant Anthracycline Plus Cyclophosphamide Followed by Taxane.
    Park S; Lee JE; Yu J; Paik HJ; Ryu JM; Kim I; Bae SY; Lee SK; Kim SW; Nam SJ; Kim EK; Kang E; Yang EJ
    Clin Breast Cancer; 2018 Feb; 18(1):e49-e54. PubMed ID: 28705541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for lymphedema after breast cancer treatment.
    Norman SA; Localio AR; Kallan MJ; Weber AL; Torpey HA; Potashnik SL; Miller LT; Fox KR; DeMichele A; Solin LJ
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2734-46. PubMed ID: 20978176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors for lymphedema of the arm after mastectomy for breast cancer].
    Kasse AA; Diop M; Dieng M; Deme A; Ndaw D; Fall MG; Diop PS; Betel E; Dembele B; Drabo B; Timbely G; Toure P
    Dakar Med; 1999; 44(1):32-5. PubMed ID: 10797983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study.
    Soran A; Ozmen T; McGuire KP; Diego EJ; McAuliffe PF; Bonaventura M; Ahrendt GM; DeGore L; Johnson R
    Lymphat Res Biol; 2014 Dec; 12(4):289-94. PubMed ID: 25495384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of a breast cancer nomogram to predict lymphedema in a Chinese population.
    Li X; Huang H; Lin Q; Yu Q; Zhou Y; Long W; Wang N
    J Surg Res; 2017 Apr; 210():132-138. PubMed ID: 28457319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
    Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
    Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05).
    Shim SJ; Park W; Huh SJ; Choi DH; Shin KH; Lee NK; Suh CO; Keum KC; Kim YB; Ahn SD; Kim SS; Ha SW; Chie EK; Kim K; Shin HS; Kim JH; Lee HS
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):65-72. PubMed ID: 24161425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience.
    Yang EJ; Ahn S; Kim EK; Kang E; Park Y; Lim JY; Kim SW
    Breast Cancer Res Treat; 2016 Nov; 160(2):269-276. PubMed ID: 27665585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy for stage II and stage III breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy.
    Le Scodan R; Selz J; Stevens D; Bollet MA; de la Lande B; Daveau C; Lerebours F; Labib A; Bruant S
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e1-7. PubMed ID: 21377284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.